Chemoinformaics analysis of 3, 7-octadiene-2,6-diol-2,6-dimethyl
Molecular Weight | 170.252 | nRot | 4 |
Heavy Atom Molecular Weight | 152.108 | nRig | 2 |
Exact Molecular Weight | 170.131 | nRing | 0 |
Solubility: LogS | -0.593 | nHRing | 0 |
Solubility: LogP | 1.413 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 30.3063 |
nHD | 2 | BPOL | 18.0577 |
QED | 0.63 |
Synth | 3.882 |
Natural Product Likeliness | 2.811 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.008 |
CACO-2 | -4.282 |
MDCK | 0.0000259 |
BBB | 0.984 |
PPB | 0.470745 |
VDSS | 1.008 |
FU | 0.486334 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.26 |
CYP2c19-inh | 0.042 |
CYP2c19-sub | 0.775 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.715 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.157 |
CYP3a4-inh | 0.184 |
CYP3a4-sub | 0.27 |
CL | 5.805 |
T12 | 0.626 |
hERG | 0.007 |
Ames | 0.006 |
ROA | 0.009 |
SkinSen | 0.502 |
Carcinogencity | 0.164 |
EI | 0.995 |
Respiratory | 0.011 |
NR-Aromatase | 0.017 |
Antiviral | No |
Prediction | 0.939017 |